The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Islam Khalid since 2023.
This trader's CIK number is 1701858.
At the time of last reporting, Islam Khalid was the Executive Chairman of Gain Therapeutics, Inc.. (stock ticker symbol GANX).
Also see all insider trading activities at Gain Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | FENC | 0 | $0 | 0 | $0 | 213,825 | $458,226 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | GANX | 50,000 | $49,950 | 0 | $0 | 0 | $0 |
1. Fennec Pharmaceuticals Inc. (FENC)
2. Gain Therapeutics, Inc. (GANX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-11-16 | FENC | Option Ex | 213,825 | 2.14 | 458,226 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-08-09 | GANX | Buy | 50,000 | 1.00 | 49,950 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Islam Khalid (Executive Chairman of Gain Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.